GRM5 and Parkinson disease: Early studies showed that the antagonism of mGlu5 was able to reduce motor deficits in PD animal models, with the acute administration of MPEP resulting in an attenuation in unilateral rotating behavior in the rat 6-OHDA-lesioned model (Spooren et al., 2000).